Revolution Medicines · 18 hours ago
Senior Director, Pipeline & Product Communications
Redwood City, California, United States
Full-time
Onsite
Director/Executive
$244K/yr - $305K/yr
15+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies. The Senior Director, Pipeline & Product Communications will lead the strategy, development, and execution of integrated communications across the company’s pipeline and product candidate portfolio, serving as a strategic advisor to cross-functional partners.
Health CareLife ScienceMedical
Responsibilities
Own and lead the integrated pipeline and product communications strategy across all stages of development, ensuring clear differentiation, scientific credibility, and alignment with corporate and business priorities
Direct communications for major clinical and regulatory milestones, including data readouts, congress presentations, trial initiations, filings, approvals, and pre-launch milestones, in close partnership with R&D, Medical Affairs, Regulatory, and Legal
Serve as the senior communications advisor for launch readiness, shaping pre-launch and launch narratives across earned media, disease education, patient engagement, and stakeholder communications, with clear linkage to future commercial strategy
Lead disease awareness and patient advocacy communications, ensuring responsible education, strong patient advocacy group partnerships, and integration of patient voice into pipeline and product storytelling
Provide strategic counsel on value, access, and product-related issues, anticipating reputational risk and leading communications response to safety updates, competitive dynamics, and external scrutiny
Drive scientific and medical thought leadership, positioning Revolution Medicines and its leaders as credible voices through publications, congress presence, executive visibility, and media engagement
Build and lead a high-performing pipeline and product communications team, setting direction, developing talent, and ensuring consistent, high-quality execution
Oversee agency partners and measurement frameworks, using insights to evaluate impact, optimize performance, and scale communications effectiveness
Qualification
Required
15+ years of experience in biotech or pharmaceutical communications, including deep experience in pipeline and product communications in-house and/or at a leading agency
Bachelor's degree required in Communications or similar; advanced degree preferred
Demonstrated success supporting clinical development, regulatory milestones, and product launches, ideally in precision oncology or a similarly complex therapeutic area
Proven people management experience, including leading teams and developing talent
Strong leadership presence with the ability to influence senior stakeholders and lead cross-functional initiatives
Deep understanding of the U.S. healthcare environment, including regulatory policy, R&D, pricing, and access
Exceptional storytelling and writing skills, with the ability to translate complex science for diverse audiences
Demonstrated experience managing sensitive issues and high-profile communications
Track record of building relationships with top-tier scientific, medical, and industry media
Preferred
Deep familiarity with precision oncology, including competitive landscapes, combination strategies, and evolving standards of care
Proven success leading communications for major regulatory milestones, including FDA approvals, advisory committee meetings, and high-stakes data readouts
Strong issues-management experience relating to global trial access and expanded access
Track record of coordinating with corporate patient advocacy and patient advocacy organizations and integrating patient voice into pipeline and product storytelling
History of leading large-scale disease education or awareness campaigns that shift understanding of disease complexity or heterogeneity
Background spanning both product and corporate communications, enabling integrated decision-making across asset narratives and enterprise reputation
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase